AKYA (Akoya) סך נכסי הפעילות העסקית

Akoya Biosciences (AKYA) management demonstrates high professionalism in developing the phenotyping platform and transparency in reporting. The visualization of total assets, valued at 133.70, confirms financial stability. The business relies on its own US-based production capacities for cell analysis systems demanded in pharmaceuticals and science, ensuring the stable output of high-tech diagnostic equipment.

This indicator, reverse-calculated via ROA, determines the total volume of resources and liabilities, serving as the foundation for assessing financial stability; in the context of Akoya Biosciences (AKYA), the total assets figure reflects the efficiency of managing in-house reagent synthesis and system assembly capacities alongside moderate component imports, where the trend line signals the balance between capital expansion and debt load optimization.